{"name":"Shanghai Zerun Biotechnology Co.,Ltd","slug":"shanghai-zerun-biotechnology-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"ZR202a-CoV","genericName":"ZR202a-CoV","slug":"zr202a-cov","indication":"Other","status":"phase_1"},{"name":"Zerun HPV-9","genericName":"Zerun HPV-9","slug":"zerun-hpv-9","indication":"Prevention of diseases caused by human papillomavirus (HPV) type 9","status":"phase_3"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"HPV-16/18 vaccine","genericName":"HPV-16/18 vaccine","slug":"hpv-16-18-vaccine","indication":"Prevention of cervical cancer caused by HPV-16 and HPV-18","status":"phase_3"}]}],"pipeline":[{"name":"HPV-16/18 vaccine","genericName":"HPV-16/18 vaccine","slug":"hpv-16-18-vaccine","phase":"phase_3","mechanism":"This vaccine stimulates the immune system to produce antibodies and cellular immunity against human papillomavirus types 16 and 18, preventing infection and associated cancers.","indications":["Prevention of cervical cancer caused by HPV-16 and HPV-18","Prevention of other HPV-16/18-associated cancers (anal, oropharyngeal, vulvar, vaginal)"],"catalyst":""},{"name":"ZR202a-CoV","genericName":"ZR202a-CoV","slug":"zr202a-cov","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Zerun HPV-9","genericName":"Zerun HPV-9","slug":"zerun-hpv-9","phase":"phase_3","mechanism":"Zerun HPV-9 is a vaccine that stimulates the body's immune response to human papillomavirus (HPV) types 9.","indications":["Prevention of diseases caused by human papillomavirus (HPV) type 9"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMizwJBVV95cUxNeUpIQXNZVy04VUptaGd1dDRMa1YwWjRHQTdsUXg2R1RuV0xlX2g5M1diZFpXNmszX1pIMjJ6SERvcmpaN1RlRmtBSWtITVVMVERMcU55UHVsZzUxTDRoVVhsZ3lpQmJVM2psYzRWZ0ZzbTF1YzJKcUM2WDRXNlJtQTZOb1NXSDJkUW9kZl9iUXE0SDNMX2htMklDd2dGNmlCbkN1c2ZpOVp2VlNzZzItS1ZBSUstclUyQ1IxcHVKYTkwUDQxRl94eVRLZnlRVEN2RGtBbnkyalNINEJucV96Vy1XTXpDWk9IdGdPdWVOVkZadGVvY21hYlRGLTdJSklnNGpuSmNKX0ZwcTJuSmJtbmJhQUtrTmthQkVINmtoWFVUWEU1ZmJZU1IwTklKX3N4Tm5rVGtuN1NMQWFqbFQ1YXh2dVZmWENTemthWm1IZw?oc=5","date":"2026-04-07","type":"regulatory","source":"Barchart.com","summary":"Common Warts Treatment Market Outlook 2034: Insights on Clinical Trials, FDA/EMA/PMDA Approvals, NDA Progress, Therapeutics, Disease Prevalence, Mechanisms, Market Size, Key Companies | DelveInsight -","headline":"Common Warts Treatment Market Outlook 2034: Insights on Clinical Trials, FDA/EMA/PMDA Approvals, NDA Progress, Therapeut","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxQM21lb25vYTRMT0hvcXhkVVJGSUtQY0x2TVZwS1piaVBrWnhsY1Bmc3pOMUJUWXNJQ1VtMVhxZ3RWbXkzT3RlbERIaExmRXFZY1RoR2RubmE5X19oX1NxS3JWMFlJV2toTXZKN3FlaERnbkxqVDFXOEo0WFZob0czQmFXQTJQbTlQUldkV2lkdS1HUVgxS1huME5Jc3d0RFJhVDJNRlNR?oc=5","date":"2026-03-31","type":"pipeline","source":"Barchart.com","summary":"Global Cancer Vaccines Market to Reach $15.0 Billion by 2032 - Barchart.com","headline":"Global Cancer Vaccines Market to Reach $15.0 Billion by 2032","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTFBTNTgtRU8tTGhGQkFRakZMTnFIWldBbzJIaUdnNE5RcHZOWHVxUVU5UFB1RXh0R09IYnZaUW5HN1FSaHdXblNKNnZWbDRERVRTMHB2RTF1LW1oYjk5ZUxvbEpFU1k2ZlE3YTBZckgxMFBBUGE0b2c?oc=5","date":"2024-12-19","type":"pipeline","source":"MarketsandMarkets","summary":"Cancer Vaccines Market worth $15.00 billion in 2032 - MarketsandMarkets","headline":"Cancer Vaccines Market worth $15.00 billion in 2032","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNNjU1M254czFkSjFMa2NZaERsMUlZcXZIWF9PNW9sUFZSWjVyM3ZOWmxDRkxza2szZWxvZk9hejEyUXFEaHRIeFo3N05sVEZIQUpXaHRodjdHOHVVd1NsVTJwVndxMEctNEw5WDVyRE5kbmZfS1RiRkc2Y1cwTC1MTW5sLTVrM1lkRzNGT3dkV1F0d2xEaVZ1MmI4WkkzYVU2MjFweW00bVI?oc=5","date":"2024-08-28","type":"pipeline","source":"Healthcare Asia Magazine","summary":"China gains strong foothold in therapeutic cancer vaccines market - Healthcare Asia Magazine","headline":"China gains strong foothold in therapeutic cancer vaccines market","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2024-08-26","type":"trial","source":"Express Pharma","summary":"China pharma firms eye stronghold in therapeutic cancer vaccines market: GlobalData - Express Pharma","headline":"China pharma firms eye stronghold in therapeutic cancer vaccines market: GlobalData","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxQU3RPenEyUF8yMnhBSVo4QUwyM1QxZ3BISDdhTHd2MThlbEg2WG1uQzc5dmZCd2hZVWU5UUV0Nm9PUnRqQkZibkd1VGtFcUh4ODkwVnBkaHQ4bU4wMVMwMXlRanhfYXZNdWFnQkU5OTBHeFJnamtvdFdSZjh5WE1EMndfMUtQWVRqN0YzV0d6cF9iemdYWHlpdTFuc3ZKaUFoUlo0NE5lVWJDU3UzeDlqRnkzQVU2RDhZWHdtVm9yLWhxaG9PbW4teUY3VlVYWTBkSFFCN0cyOXJYdGppa0Nz?oc=5","date":"2023-12-22","type":"trial","source":"PharmiWeb.com","summary":"Coxsackievirus Treatment Market Commands a Noteworthy US$ 5.5 Billion Valuation in 2023-FMI Study - PharmiWeb.com","headline":"Coxsackievirus Treatment Market Commands a Noteworthy US$ 5.5 Billion Valuation in 2023-FMI Study","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"phase_3":2,"phase_1":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}